{
    "2021-06-23": [
        [
            {
                "time": "",
                "original_text": "医药股在香港集体爆发 行业多重利好催化审评审批效率提速",
                "features": {
                    "keywords": [
                        "医药股",
                        "香港",
                        "爆发",
                        "多重利好",
                        "审评审批",
                        "效率提速"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中泰证券：药品审评审批“速”“质”提升，全面利好医药行业发展",
                "features": {
                    "keywords": [
                        "中泰证券",
                        "药品",
                        "审评审批",
                        "速",
                        "质",
                        "提升",
                        "利好",
                        "医药行业"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}